Bivalent BNT162b2 mRNA original/omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared with the monovalent COVID-19 booster.

Wagenhäuser I., Reusch J., Gabel A., Krone LB., Kurzai O., Petri N., Krone M.

DOI

10.1016/j.cmi.2023.01.008

Type

Journal article

Publication Date

2023-04-01T00:00:00+00:00

Volume

29

Pages

554 - 556

Total pages

2

Keywords

Humans, BNT162 Vaccine, COVID-19, Vaccination

Permalink More information Close